Reducing this ratio, whether by affecting BACE (β-site APP cleaving enzyme) or other cleavage of APP, appears to mitigate the AD severity (Bredesen et al, 2010; Galvan et al, 2006; Jonsson et al, 2012). Here, APP is linked to Alzheimer disease.